Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 323-326

  Bamberger, Joshua D ^a   Waldo, Craig R ^c   Gerberding, Julie Louise ^d   Katz, Mitchell H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INDINAVIR; LAMIVUDINE; NELFINAVIR; STAVUDINE; ZIDOVUDINE;

ASSAULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAPE; REVIEW; SEXUAL CRIME; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0033105807     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00018-2     Document Type: Article

References (22)

1. Katz M., Gerberding J. The care of persons with recent sexual exposure to HIV. Ann Intern Med. 128:1998;306-312.
2. Cardo D.M., Culver D.H., Ciesielski C.A., et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. NEJM. 337:1997;1485-1490.
3. Gostin L.O., Lazzarini Z., Alexander D., et al. HIV testing, counseling, and prophylaxis after sexual assault. JAMA. 271:1994;1436-1444.
4. Guidelines for treatment of sexually transmitted diseases. MMRW. 47:1998;109-111.
5. Koss M. The underdetection of rape methodological choices influence incidence estimates . J Soc Iss. 48:1992;61-75.
6. National Women's Study. Rape in America A Report to the Nation . 1992;National Victim Center and Crime Victims Research and Treatment Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston.
7. Albert J., Wahlberg J., Leitner T., et al. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol. 68:1994;5918-5924.
8. Claydon E., Murphy S., Osborne E.M., et al. Rape and HIV. Int J STD AIDS. 2:1991;200-201.
9. Kapiga S., Shao J., Lwihula G., Hunter D. Risk factors for HIV infection among women in Dar-es-Salaam, Tanzania. J Acquir Immune Defic Syndr. 7:1994;301-309.
10. Gore S., Bird A., Burns S., et al. Anonymous HIV surveillance with risk-factor elicitation at Perth (for men) and Cornton Vale (for women) prisons in Scotland . Int J STD AIDS. 8:1997;166-175.
11. Gerberding J. Prophylaxis for occupational exposure to HIV. Ann Intern Med. 125:1996;497-501.
12. Belec L., Matta M., Payan C., et al. Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim . J Med Vir. 45:1995;113-116.
13. Kaplan E., Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr. 5:1992;1116-1118.
14. Royce R., Sena A., Cates W.J., Cohen M. Sexual transmission of HIV. NEJM. 336:1997;1072-1078.
15. Jenny C., Hooton T.M., Bowers A., et al. Sexually transmitted diseases in victims of rape. NEJM. 322:1990;713-716.
16. Goodman L., Koss M., Russo N. Violence against women: physical and mental health effects: II. Research findings. Appl Prev Psychol. 2:(2):1993;79-89.
17. Hampton H.L. Care of the woman who has been raped. NEJM. 332:1995;234-237.
18. Sicoli R., Losek J., Hudlett J., Smith D. Indications for Neisseria gonorrhoeae cultures in children with suspected sexual abuse. Arch Pediatr Adolesc Med. 149:1995;86-89.
19. Guidelines for the use of antiretroviral agents in pediatric HIV infection. National Pediatric and Family HIV Resource Center. 1998;Health Resources and Services Administration, National Institutes of Health.
20. Groth A.N., Burgess A.W. Male rape offenders and victims . Am J Psychiatry. 137:1980;806-810.
21. Pinkerton S., Holtgrave D., Bloom F. Postexposure treatment for HIV. NEJM. 337:1997;500-501. Letter.
22. Larkin H, Cosby C, Pettiti L, et al. The seroprevalence of HIV and other STD's in sexual assault suspects and victims. 12th World AIDS Conference, Geneva, June 28-July 3, 1998. Abstract.